FAS and cancer: There are at least three short mRNA variants of FAS missing the encoded transmembrane domain and the resulting translated protein isoforms are presumably secreted by cancer cells and act as decoy receptors for the FAS ligand, thus allowing cancer cells to escape from apoptosis [38,39].